Shares of health and wellness products company USANA Health Sciences (NYSE:USNA) jumped 11.5% in the morning session after the company reported first-quarter results with revenue narrowly exceeding Wall Street's expectations, though EPS beat by a more convincing amount. The topline benefitted from sales incentives in mainland China, which drove active customer growth. However, the company noted that other key markets did not meet internal expectations. In addition, its gross margin and full-year
USANA Health (USNA) delivered earnings and revenue surprises of 24.64% and 2.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Despite a Dip in Net Sales, EPS Exceeds Analyst Expectations